The Microbiome in Mental Health: Potential Contribution of Gut Microbiota in Disease and Pharmacotherapy Management

Pharmacotherapy

Volumn 35, Issue 10, 2015, Pages 910-916

  Flowers, Stephanie A ^a   Ellingrod, Vicki L ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

drug metabolism; metagenomics; microbiome; psychiatry

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BILE ACID; CITALOPRAM; CLONAZEPAM; CYTOKINE; DOXYCYCLINE; LEVODOPA; MINOCYCLINE; OLANZAPINE; PROBIOTIC AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SHORT CHAIN FATTY ACID; TRICYCLIC ANTIDEPRESSANT AGENT; AUTACOID; FATTY ACID;

ADD ON THERAPY; AUTISM; BACTERIAL TRANSLOCATION; BACTEROIDES; BLOOD BRAIN BARRIER; CARDIOVASCULAR DISEASE; DRUG BLOOD LEVEL; DRUG METABOLISM; FIRMICUTES; HELICOBACTER PYLORI; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE INNERVATION; INTESTINE MUCOSA PERMEABILITY; MAJOR DEPRESSION; MENTAL DISEASE; NONHUMAN; OBESITY; PARKINSON DISEASE; PERSONALIZED MEDICINE; REVIEW; SCHIZOPHRENIA; AFFECT; ANIMAL; BRAIN; DIET; GASTROINTESTINAL TRACT; INFLAMMATION; MENTAL HEALTH; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AFFECT; ANIMALS; BILE ACIDS AND SALTS; BLOOD-BRAIN BARRIER; BRAIN; DIET; FATTY ACIDS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MENTAL DISORDERS; MENTAL HEALTH;

EID: 84945130171     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1640     Document Type: Review

References (68)

1. Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett C, Knight R, Gordon JI,. The human microbiome project: exploring the microbial part of ourselves in a changing world. Nature 2007; 449 (7164): 804-10.
2. Hugenholtz P, Tyson GW,. Microbiology metagenomics. Nature 2008; 455: 481-3.
3. Maurice CF, Haiser HJ, Turnbaugh PJ,. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013; 2: 39-50.
4. Roshchina VV,. Evolutionary considerations of neurotransmitters in microbial, plant, and animal cells. In:, Lyte M, Freestone PPE, eds. Microbial Endocrinology: Interkingdom Signaling in Infectious Disease and Health. New York, Dordrecht, Heidelberg, London: Springer Science+Business Media, 2010: 17-52.
5. Iyer LM, Aravind L, Coon SL, Klein DC, Koonin EV,. Evolution of cell-cell signaling in animals: did late horizontal gene transfer from bacteria have a role? Trends Genet 2004; 20 (7): 292-9.
6. Guthrie GD, Nicholson-Guthrie CS, Leary HL,. A bacterial high-affinity GABA binding protein: isolation and characterization. Biochem Biophys Res Commun 2000; 268 (1): 65-8.
7. Kabouridis PS, Pachnis V,. Emerging roles of gut microbiota and the immune system in the development of the enteric nervous system. J Clin Invest 2015; 125 (3): 956-64.
8. Zhou L, Foster JA,. Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat 2015; 11: 715-23.
9. Min YW, Rhee P-L,. The role of microbiota on the gut immunology. Clin Ther 2015; 37 (5): 968-75. doi: 10.1016/j.clinthera.2015.03.009.
10. Braniste V, Al-Asmakh M, Kowa C, et al., The gut microbiota influences the blood brain barrier permeability in mice. Sci Transl Med 2014; 6 (263): 263ra158.
11. Severance EG, Yolken RH, Eaton WW,. Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling. Schizophr Res 2014. DOI: http://dx.doi.org/10.1016/j.schres.2014.06.027.
12. Lydiard RB,. Irritable bowel syndrome, anxiety, and depression: what are the links? J Clin Psychiatry 2001; 62 (Suppl 8): 38-45; discussion 46-7.
13. Matcham F, Rayner L, Steer S, Hotopf M,. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 2013; 52 (12): 2136-48.
14. Macfarlane GT, Macfarlane S,. Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 2012; 95 (1): 50-60.
15. Cummings JH,. Short chain fatty acids in the human colon. Gut 1981; 22 (9): 763-79.
16. Donohoe DR, Garge N, Zhang X, Sun W, O'Connell TM, Bunger MK, Bultman SJ, The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. Cell Metab 2011; 13 (5): 517-26.
17. De Theije CGM, Wopereis H, Ramadan M, et al., Altered gut microbiota and activity in a murine model of autism spectrum disorders. Brain Behav Immun 2014; 37: 197-206.
18. Smith PM, Howitt MR, Panikov N, et al., The microbial metabolites, short chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341: 6145.
19. Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH, Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Nature 2015; 8: 80-93.
20. Li T, Chiang JYL,. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014; 66 (4): 948-83.
21. Allen K, Jaeschke H, Copple BL,. Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis. Am J Pathol 2011; 178 (1): 175-86.
22. Nguyen A, Bouscarel B,. Bile acids and signal transduction: role in glucose homeostasis. Cell Signal 2008; 20 (12): 2180-97.
23. Kawamata Y, Fujii R, Hosoya M, et al., A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003; 278 (11): 9435-40.
24. Thomas C, Pellicciari R, Pruzanski M, Auwerx J, Schoonjans K,. Targeting bile-acid signalling for metabolic diseases. Nat Rev Drug Discov 2008; 7 (8): 678-93.
25. Cantorna MT, Waddell A,. The vitamin D receptor turns off chronically activated T cells. Ann N Y Acad Sci 2014; 1317: 70-7525.
26. Ogura M, Nishida S, Ishizawa M, et al., Vitamin D3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice. J Pharmacol Exp Ther 2009; 328 (2): 564-70.
27. Hofmann AF, Eckmann L,. How bile acids confer gut mucosal protection against bacteria. Proc Natl Acad Sci U S A 2006; 103 (12): 4333-4.
28. Li H, Jia W,. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity. Clin Pharmacol Ther [Internet]. 2013; 94 (5): 574-81.
29. Elmer GW, Remmel RP,. Role of the intestinal microflora in clonazepam metabolism in the rat. Xenobiotica 1984; 14 (11): 829-40.
30. Taylor K, Elliott S,. An unusual case of risperidone instability in a fatality presenting an analytical and interpretative challenge. Drug Test Anal 2013; 10: 748-52.
31. Fiddian-Green RG,. Helicobacter pylori eradication and L-dopa absorption in patients with PD and motor fluctuations. Neurology 2007; 68 (13): 1085.
32. Meinl W, Sczesny S, Brigelius-Flohé R, Blaut M, Glatt H,. Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metab Dispos 2009; 37 (6): 1179-86.
33. Claus SP, Ellero SL, Berger B, et al., Colonization-induced host-gut microbial metabolic interaction. MBio 2011; 2 (2): e00271 -10.
34. Noto C, Rizzo LB, Mansur RB, McIntyre RS, Maes M, Brietzke E,. Targeting the inflammatory pathway as a therapeutic tool for major depression. NeuroImmunoModulation 2014; 21 (2-3): 131-9.
35. Leonard B, Maes M,. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev 2012; 36 (2): 764-85.
36. Liu D, Wang Z, Liu S, Wang F, Zhao S, Hao A,. Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells. Neuropharmacology 2011; 61 (4): 592-9.
37. Ohgi Y, Futamura T, Kikuchi T, Hashimoto K,. Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration. Pharmacol Biochem Behav 2013; 103 (4): 853-9.
38. Maes M, Kubera M, Leunis J-C,. The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008; 29 (1): 117-24.
39. Julio-Pieper M, Bravo JA, Aliaga E, Gotteland M,. Review article: intestinal barrier dysfunction and central nervous system disorders- A controversial association. Aliment Pharmacol Ther 2014; 40 (10): 1187-201.
40. Ait-Belgnaoui A, Bradesi S, Fioramonti J, Theodorou V, Bueno L,. Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinase. Pain 2005; 113 (1-2): 141-7.
41. Bravo JA, Forsythe P, Chew MV, et al., Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci U S A 2011; 108 (38): 16050-5.
42. Oya K, Kishi T, Iwata N,. Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials. Hum Psychopharmacol 2014; 29 (5): 483-91.
43. Dean OM, Maes M, Ashton M, et al., Protocol and rationale-the efficacy of minocycline as an adjunctive treatment for major depressive disorder: a double blind, randomised, placebo controlled trial. Clin Psychopharmacol Neurosci 2014; 12 (3): 180-8.
44. Mello BSF, Monte AS, McIntyre RS, et al., Effects of doxycycline on depressive-like behavior in mice after lipopolysaccharide (LPS) administration. J Psychiatr Res 2013; 47 (10): 1521-9.
45. Morimoto N, Shimazawa M, Yamashima T, Nagai H, Hara H,. Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage. Brain Res 2005; 1044 (1): 8-15.
46. Homsi S, Federico F, Croci N, et al., Minocycline effects on cerebral edema: relations with inflammatory and oxidative stress markers following traumatic brain injury in mice. Brain Res 2009; 1291: 122-32.
47. McEvoy JP, Meyer JM, Goff DC, et al., Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80 (1): 19-32.
48. Osby U, Correia N, Brandt L, Ekbom A, Sparén P,. Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study. BMJ 2000; 321 (7259): 483-4.
49. Hansen V, Jacobsen BK, Arnesen E,. Cause-specific mortality in psychiatric patients after deinstitutionalisation. Br J Psychiatry 2001; 179: 438-43.
50. Davey KJ, O'Mahony SM, Schellekens H, et al., Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology 2012; 221 (1): 155-69.
51. Davey KJ, Cotter PD, O'Sullivan O, et al., Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat. Transl Psychiatry 2013; 3: e309.
52. Ley RE, Turnbaugh PJ, Klein S, Gordon JI,. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444 (7122): 1022-3.
53. Morgan AP, Crowley JJ, Nonneman RJ, et al., The antipsychotic olanzapine interacts with the gut microbiome to cause weight gain in mouse. PLoS ONE 2014; 9 (12): e115225.
54. Sanders ME, Lenoir-Wijnkoop I, Salminen S, et al., Probiotics and prebiotics: prospects for public health and nutritional recommendations. Ann N Y Acad Sci 2014; 1309: 19-29.
55. Desbonnet L, Garrett L, Clarke G, Kiely B, Cryan JF, Dinan TG,. Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 2010; 170 (4): 1179-88.
56. Neufeld KM, Kang N, Bienenstock J, Foster JA,. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23 (3): 255-64.
57. Goehler LE, Park SM, Opitz N, Lyte M, Gaykema RP,. Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun 2008; 22 (3): 354-66.
58. Steinberg R, Lima M, Gomes de Oliveira NL, et al., Effect of intestinal colonization by two Lactobacillus strains on the immune response of gnotobiotic mice. Benef Microbes 2014; 5 (4): 409-19.
59. Zareie M, Johnson-Henry K, Jury J, et al., Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 2006; 55 (11): 1553-60.
60. Ait-Belgnaoui A, Durand H, Cartier C, et al., Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 2012; 37: 1885-95.
61. Tillisch K, Labus J, Kilpatrick L, et al., Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013; 144 (7): 1394-401, 1401.e1-4.
62. Benton D, Williams C, Brown A,. Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2007; 61 (3): 355-61.
63. Messaoudi M, Lalonde R, Violle N, et al., Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011; 105 (5): 755-64.
64. Schmidt K, Cowen PJ, Harmer CJ, Tzortzis G, Errington S, Burnet PW,. Prebiotic intake reduces the waking cortisol response and alters emotional bias in healthy volunteers. Psychopharmacology 2015; 232 (10): 1793-801.
65. Rao AV, Bested AC, Beaulne TM, et al., A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009; 1 (1): 6.
66. Tomasik J, Yolken RH, Bahn S, Dickerson FB,. Immunomodulatory effects of probiotic supplementation in schizophrenia patients: a randomized, placebo-controlled trial. Biomark Insights 2015; 10: 47-54.
67. Schloss PD, Handelsman J,. Status of the microbial census. Microbiol Mol Biol Rev 2004; 68 (4): 686-91.
68. Abram F,. Systems-based approaches to unravel multi-species microbial community functioning. Comput Struct Biotechnol J 2014; 13: 24-32.